ÀÓÇöõÆ®ÁÖÀ§ÁúȯÀÇ À¯º´À², Áø´Ü, Ä¡·á ±×¸®°í ÇÑ°è
Peri-implant diseases: prevalence, diagnosis, treatment and limitations
ÁÖÁö¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÁÖÁö¿µ ( Joo Ji-Young ) - Pusan National University School of Dentistry Department of Periodontology
Abstract
Peri-implant diseases are prevalent with a weighted mean prevalence rate of 43% across Europe and 22% across South and North America. Although the main etiologic agent is bacterial biofilm, various factors influence the initiation and progression of the disease. Unfortunately, the treatment of peri-implant diseases is at best favorable in the short term with a high rate of persistent inflammation and recurrence. Therefore, it is sensible to consider and control all potential factors that may predispose an implant to peri-implant tissue inflammation in an attempt to avoid the disease. If periodic maintenance treatment is not performed, there is a high probability of recurrence of the disease and can lead to the loss of the implant.
Å°¿öµå
Peri-implant diseases; Peri-implantitis; Peri-implant mucositis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸